"premas-biotech"

Company in talks with global pharma companies to explore possibility to use the technology to make vaccines in their countries

Indian partner plans to manufacture, test and commercialise the injectable vaccine in the country where the Covid-19 vaccine market is expected to grow to over $2.3 billion by 2027

Partnering with long-term collaborator Oramed by creating a JV firm to develop Covid oral vaccine using virus-like particle technology